← Back to Search

Compression Device

Compression Therapy for Arm Weakness

N/A
Recruiting
Led By Suzanne Langley, OT
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a device that wraps around the leg and uses gentle pressure to help blood flow. It aims to help patients with partial paralysis on one side of their body by improving movement and sensation in their affected arm, while also reducing the risk of blood clots.

Who is the study for?
This trial is for post-stroke patients at Mayo Clinic/Jacksonville with weakness in one arm, who can agree to participate and have a certain level of motor function. They must be able to communicate pain and not have conditions like recent surgery, active wounds, or severe blood vessel problems in the affected arm.
What is being tested?
The study tests if using a Sequential Compression Device (SCD) with a sleeve on the weak arm of stroke survivors is safe. It's applied to those whose upper extremity has been weakened due to stroke.
What are the potential side effects?
While specific side effects are not listed, the device may cause discomfort or potential issues in the treated limb such as swelling or skin irritation based on similar devices' profiles.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Wearing tolerance of the SCD and sleeve on the upper extremity.
Secondary study objectives
Medical Devices
Other study objectives
Edema measured in inches of circumference of forearm
Nail bed Color
UE Strength using Motor Arm subsection #5 of NIH scale
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sequential Compression Device (SCD) on upper extremityExperimental Treatment1 Intervention
Subjects post stroke with upper extremity weakness have the SCD sleeve placed on the arm for up to 4 hours for one day only

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for stroke aim to restore blood flow to the brain and prevent further clot formation. Mechanical thrombectomy involves the physical removal of a blood clot from a blocked artery using stent retrievers or aspiration devices, which can significantly improve outcomes if performed promptly. Anticoagulant therapy, such as the use of heparin or warfarin, helps to prevent new clots from forming and existing clots from growing, reducing the risk of recurrent strokes. Sequential Compression Devices (SCDs) and similar compression therapies improve blood flow and prevent clot formation by applying intermittent pressure to the limbs, which is particularly useful for patients with limited mobility. These treatments are crucial for stroke patients as they help to minimize brain damage, improve recovery outcomes, and reduce the risk of complications such as deep vein thrombosis.
Intra-arterial mechanical thrombectomy stent retrievers and aspiration devices in the treatment of acute ischaemic stroke: A systematic review and meta-analysis with trial sequential analysis.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,332 Previous Clinical Trials
3,059,891 Total Patients Enrolled
24 Trials studying Stroke
10,959 Patients Enrolled for Stroke
Suzanne Langley, OTPrincipal InvestigatorMayo Clinic

Media Library

Lower Extremity Sleeve and Pump Device (Compression Device) Clinical Trial Eligibility Overview. Trial Name: NCT05535257 — N/A
Stroke Research Study Groups: Sequential Compression Device (SCD) on upper extremity
Stroke Clinical Trial 2023: Lower Extremity Sleeve and Pump Device Highlights & Side Effects. Trial Name: NCT05535257 — N/A
Lower Extremity Sleeve and Pump Device (Compression Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05535257 — N/A
~6 spots leftby Nov 2025